Showing 3861-3870 of 5773 results for "".
- EssilorLuxottica Closes Acquisition of Walman Opticalhttps://modernod.com/news/essilorluxottica-closes-acquisition-of-walman-optical/2480668/EssilorLuxottica announces today the closing of its acquisition of U.S.-based lab network Walman Optical, a leading lab partner to vision care practices around the country. First announced in March 2021, the acquisition will draw on EssilorLuxottica’s focus on product and service innovation
- VEO Ophthalmics Teams Up with Aniridia Foundation International To Promote Rare Disease Dayhttps://modernod.com/news/veo-ophthalmics-teams-up-with-aniridia-foundation-international-to-promote-rare-disease-day/2480667/VEO Ophthalmics announced that it is collaborating with Aniridia Foundation International (AFI) to raise awareness for aniridia and its associated treatment options. VEO is proud to support AFI in their mission to help advance research and provide educational programs to the
- Aerie Pharmaceuticals Appoints Gary Sternberg, MD, MBA, as Chief Medical Officerhttps://modernod.com/news/aerie-pharmaceuticals-appoints-gary-sternberg-md-mba-as-chief-medical-officer/2480665/Aerie Pharmaceuticals announced that Gary Sternberg, MD, MBA, will join the company as Chief Medical Officer (CMO), effective March 1, 2022. He will report to Raj Kannan, Chief Executive Officer of Aerie Pharmaceuticals and become a member of the Aerie Executive Comm
- Phase 4 Study of Iluvien for DME Shows Statistically Significant Improvements in BCVA, CST, and Treatment Burden at 36 Monthshttps://modernod.com/news/phase-4-paladin-study-with-iluvien-published-in-peer-reviewed-journal-ophthalmology/2480659/Alimera Sciences announced that the 3-year results of the PALADIN study have been published in the peer-reviewed journal Ophthalmology. These study results show that patients with diabetic macular edema (DME) who received a single dose of the sustained release implant Iluv
- Italian Patients Receive Samsara Vision’s SING IMT, a New Technology for Age-Related Macular Degenerationhttps://modernod.com/news/italian-patients-receive-samsara-visions-sing-imt-a-new-technology-for-age-related-macular-degeneration/2480658/Samsara Vision announced the first three successful clinical cases in Italy using its SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) for people living with late-stage, age-related macular degeneration (AMD). The SING IMT was successfully implanted in patients
- Nicox Granted New Patent for NCX 4251 in Japanhttps://modernod.com/news/nicox-granted-new-patent-for-ncx-4251-in-japan/2480657/Nicox SA announced that the Japanese Patent Office has granted a new patent expiring in 2040 covering the company’s product candidate NCX 4251. Patent JP.7021301 covers ophthalmic suspensions comprising a specific form of fluticasone p
- Nicox Granted Patent for NCX 470 in China, Extending Coverage to 2039https://modernod.com/news/nicox-granted-patent-for-ncx-470-in-china-extending-coverage-to-2039/2480655/Nicox SA announced that the Chinese National Intellectual Property Administration (CNIPA) has granted the company a formulation patent for NCX 470, its lead product candidate in development for patients with open-angle glaucoma or ocular hypertension, extending coverage in China to 2039. Wit
- Alpine and Shamir Extend Strategic Partnership Into Esports Worldhttps://modernod.com/news/alpine-and-shamir-extend-strategic-partnership-into-esports-world/2480654/Shamir has announced a multi-year extension to its partnership with Alpine F1 Team, becoming the optical performance partner of Alpine Esports Team. Shamir will provide ophthalmic assessments and improvement of gaming performance, and endurance through cutting edge lenses and
- Switzerland Eye Research Institute Publishes Breakthrough Case Report Using Light Exposure and Nutraceuticals for Treating Retinal Degenerationhttps://modernod.com/news/switzerland-eye-research-institute-publishes-breakthrough-case-report-using-light-exposure-and-nutraceuticals-for-treating-retinal-degeneration/2480653/Roberto Pinelli, MD, CEO of the Switzerland Eye Research Institute, announced the publication of a breakthrough paper in Archives Italiennes de Biologie. The report can be found here:
- Lensbox Launches 480+ First-to-Market Eye Care Patient Experience Centers in the US and Canadahttps://modernod.com/news/lensbox-launches-480-first-to-market-eyecare-patient-experience-centers-in-the-us-and-canada/2480652/Lensbox has announced the launch of 480+ Lensbox EyeDocs. The "bricks and clicks technology" features fully automated patient experience centers that integrate with the Lensbox first-to-market app, tying in tele-optometry, e-commerce, and point-of-sale technology for